Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer's Disease and Other Neurodegenerative Diseases
- PMID: 35897658
- PMCID: PMC9331765
- DOI: 10.3390/ijms23158082
Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer's Disease and Other Neurodegenerative Diseases
Abstract
Alzheimer's disease (AD) is considered the most prevalent neurodegenerative disease and the leading cause of dementia worldwide. Sphingolipids, such as ceramide or sphingosine 1-phosphate, are bioactive molecules implicated in structural and signaling functions. Metabolic dysfunction in the highly conserved pathways to produce sphingolipids may lead to or be a consequence of an underlying disease. Recent studies on transcriptomics and sphingolipidomics have observed alterations in sphingolipid metabolism of both enzymes and metabolites involved in their synthesis in several neurodegenerative diseases, including AD. In this review, we highlight the most relevant findings related to ceramide and neurodegeneration, with a special focus on AD.
Keywords: Alzheimer’s disease; ceramide; metabolism; sphingolipidomics; sphingolipids; sphingosine 1-phosphate; tau; β-amyloid.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- World Health Organization (WHO) Global Action Plan on the Public Health Response to Dementia 2017–2025. Volume 27 World Health Organization; Geneva, Switzerland: 2017.
-
- Javaid S.F., Giebel C., Khan M.A., Hashim M.J. Epidemiology of Alzheimer’s Disease and Other Dementias: Rising Global Burden and Forecasted Trends. F1000Research. 2021;10:425. doi: 10.12688/f1000research.50786.1. - DOI
-
- Nichols E., Abd-Allah F., Abdoli A., Abosetugn A.E., Abrha W.A., Abualhasan A., Abu-Gharbieh E., Akinyemi R.O., Alahdab F., Alanezi F.M., et al. Global Mortality from Dementia: Application of a New Method and Results from the Global Burden of Disease Study 2019. Alzheimer’s Dement. Transl. Res. Clin. Interv. 2021;7:e12200. doi: 10.1002/TRC2.12200. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
